Eyad Almasri

1.9k total citations
31 papers, 804 citations indexed

About

Eyad Almasri is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Cancer Research. According to data from OpenAlex, Eyad Almasri has authored 31 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pediatrics, Perinatology and Child Health, 11 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Eyad Almasri's work include Prenatal Screening and Diagnostics (15 papers), Cancer Genomics and Diagnostics (9 papers) and Fetal and Pediatric Neurological Disorders (8 papers). Eyad Almasri is often cited by papers focused on Prenatal Screening and Diagnostics (15 papers), Cancer Genomics and Diagnostics (9 papers) and Fetal and Pediatric Neurological Disorders (8 papers). Eyad Almasri collaborates with scholars based in United States, Australia and United Kingdom. Eyad Almasri's co-authors include John A. Kellum, Mingchen Song, Ron McCullough, Daniel S. Grosu, Juan‐Sebastian Saldivar, Mathias Ehrich, Theresa Boomer, John A. Tynan, Amin R. Mazloom and Daniel H. Farkas and has published in prestigious journals such as Blood, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Eyad Almasri

29 papers receiving 774 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eyad Almasri United States 13 474 197 189 143 131 31 804
A Fanconi Switzerland 16 149 0.3× 183 0.9× 261 1.4× 29 0.2× 19 0.1× 43 715
Hayato Go Japan 11 111 0.2× 24 0.1× 112 0.6× 24 0.2× 27 0.2× 65 442
Francine Brambate Carvalhinho Lemos Brazil 13 90 0.2× 24 0.1× 112 0.6× 39 0.3× 15 0.1× 26 541
Lisa White United States 14 55 0.1× 158 0.8× 150 0.8× 17 0.1× 27 0.2× 28 1.0k
Joo Guan Yeo Singapore 14 23 0.0× 30 0.2× 175 0.9× 70 0.5× 26 0.2× 34 688
Shaul G. Massry United States 12 58 0.1× 44 0.2× 116 0.6× 26 0.2× 11 0.1× 20 467
Xia Qiu China 13 39 0.1× 25 0.1× 76 0.4× 76 0.5× 28 0.2× 36 520
Jorge Reis Almeida Brazil 14 93 0.2× 8 0.0× 83 0.4× 73 0.5× 15 0.1× 44 455
Friederike Jochimsen Germany 9 47 0.1× 129 0.7× 144 0.8× 10 0.1× 6 0.0× 14 556

Countries citing papers authored by Eyad Almasri

Since Specialization
Citations

This map shows the geographic impact of Eyad Almasri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eyad Almasri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eyad Almasri more than expected).

Fields of papers citing papers by Eyad Almasri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eyad Almasri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eyad Almasri. The network helps show where Eyad Almasri may publish in the future.

Co-authorship network of co-authors of Eyad Almasri

This figure shows the co-authorship network connecting the top 25 collaborators of Eyad Almasri. A scholar is included among the top collaborators of Eyad Almasri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eyad Almasri. Eyad Almasri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fayed, Mohamed, et al.. (2024). Overview of the Current Challenges in Pulmonary Coccidioidomycosis. Journal of Fungi. 10(10). 724–724. 3 indexed citations
2.
Jensen, Tomas Ø., Shaili Gupta, Sean Liu, et al.. (2024). Impact of Baseline SARS-CoV-2 Load in Plasma and Upper Airways on the Incidence of Acute Extrapulmonary Complications of COVID-19: A Multicentric, Prospective, Cohort Study. Clinical Infectious Diseases. 79(6). 1394–1403. 2 indexed citations
3.
Almasri, Eyad, et al.. (2023). Positive cfDNA screening results for 22q11.2 deletion syndrome—Clinical and laboratory considerations. Frontiers in Genetics. 14. 1146669–1146669. 6 indexed citations
4.
Tynan, John A., Clare Gibbons, Wendy S. Meschino, et al.. (2023). Laboratory performance of genome-wide cfDNA for copy number variants as compared to prenatal microarray. Molecular Cytogenetics. 16(1). 10–10. 1 indexed citations
5.
Jensen, Taylor J., Aaron M. Goodman, Christopher K. Ellison, et al.. (2021). Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible. Molecular Cancer Therapeutics. 20(11). 2274–2279. 7 indexed citations
6.
Goodman, Aaron M., Lisa Kim, Kerry Fitzgerald, et al.. (2021). Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas. Transplantation and Cellular Therapy. 28(1). 30.e1–30.e7. 18 indexed citations
7.
Boomer, Theresa, et al.. (2021). Three years of clinical experience with a genome-wide cfDNA screening test for aneuploidies and copy-number variants. Genetics in Medicine. 23(7). 1349–1355. 29 indexed citations
8.
Almasri, Eyad, et al.. (2021). Genome-wide cell-free DNA screening: a focus on copy-number variants. Genetics in Medicine. 23(10). 1847–1853. 15 indexed citations
9.
Almasri, Eyad, et al.. (2021). Application of mosaicism ratio to multifetal gestations. PLoS ONE. 16(3). e0248467–e0248467. 1 indexed citations
10.
Tynan, John A., et al.. (2020). Impact of mosaicism ratio on positive predictive value of cfDNA screening. Prenatal Diagnosis. 41(1). 28–34. 14 indexed citations
11.
Dharajiya, Nilesh, Daniel S. Grosu, Daniel H. Farkas, et al.. (2017). Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing. Clinical Chemistry. 64(2). 329–335. 66 indexed citations
12.
Ehrich, Mathias, John A. Tynan, Amin R. Mazloom, et al.. (2017). Genome-wide cfDNA screening: clinical laboratory experience with the first 10,000 cases. Genetics in Medicine. 19(12). 1332–1337. 46 indexed citations
13.
Lefkowitz, Roy B., John A. Tynan, Tong Liu, et al.. (2016). Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants. American Journal of Obstetrics and Gynecology. 215(2). 227.e1–227.e16. 134 indexed citations
16.
Larsen, Peter E., et al.. (2006). Sample Scale-Free Gene Regulatory Network Using Gene Ontology. PubMed. 89. 5523–5526. 1 indexed citations
18.
Hill, Warren G., et al.. (2005). Water and solute permeability of rat lung caveolae: high permeabilities explained by acyl chain unsaturation. American Journal of Physiology-Cell Physiology. 289(1). C33–C41. 14 indexed citations
19.
Almasri, Eyad, Mingchen Song, & John A. Kellum. (2004). EFFECTS OF HYPERCHLOREMIC ACIDOSIS ON CIRCULATING CYTOKINES IN EXPERIMENTAL SEPSIS IN RATS. Critical Care Medicine. 32(Supplement). A141–A141. 1 indexed citations
20.
Almasri, Eyad, et al.. (2002). CASE REPORT: Sumatriptan-Associated Ischemic Colitis. Digestive Diseases and Sciences. 47(9). 2015–2016. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026